CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$ 1,625	$ 4,065	$ 1,158
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, depletion and amortization	1,641	1,635	693
Deferred income tax expense	74	235	126
(Gain) loss on sale of assets	(12)	1	2
(Gain) loss on derivative instruments	(230)	463	221
Net cash received (paid) in settlement of derivative instruments	284	(762)	(431)
Amortization of debt premium and debt issuance costs	(18)	(40)	(10)
Gain on debt extinguishment	0	(28)	0
Stock-based compensation and other	57	73	52
Changes in assets and liabilities:
Accounts receivable, net	378	(184)	(229)
Income taxes	38	(118)	34
Inventories	4	(24)	5
Other current assets	(3)	(4)	(4)
Accounts payable and accrued liabilities	(180)	96	47
Interest payable	0	(5)	6
Other assets and liabilities	0	53	(3)
Net cash provided by operating activities	3,658	5,456	1,667
CASH FLOWS FROM INVESTING ACTIVITIES
Capital expenditures for drilling, completion and other fixed asset additions	(2,089)	(1,700)	(723)
Capital expenditures for leasehold and property acquisitions	(10)	(10)	(5)
Proceeds from sale of assets	40	36	8
Cash received from Merger	0	0	1,033
Net cash (used in) provided by investing activities	(2,059)	(1,674)	313
CASH FLOWS FROM FINANCING ACTIVITIES
Borrowings from debt	0	0	100
Repayments of debt	0	(874)	(288)
Repayments of finance leases	(6)	(6)	(2)
Common stock repurchases	(405)	(1,250)	0
Dividends paid	(890)	(1,992)	(780)
Cash paid for conversion of redeemable preferred stock	(1)	(10)	0
Tax withholding on vesting of stock awards	(10)	(25)	(114)
Capitalized debt issuance costs	(7)	0	(4)
Cash received for stock option exercises	2	12	2
Net cash used in financing activities	(1,317)	(4,145)	(1,086)
Net increase (decrease) in cash, cash equivalents and restricted cash	282	(363)	894
Cash, cash equivalents and restricted cash, beginning of period	683	1,046	152
Cash, cash equivalents and restricted cash, end of period	$ 965	$ 683	$ 1,046